Evidence map›Paper›PMID 29634780›Full record

ArticlePloS one2018

Proteomic analysis of human epileptic neocortex predicts vascular and glial changes in epileptic regions.

Gal Keren-Aviram, Fabien Dachet, Shruti Bagla, Karina Balan, Jeffrey A Loeb, Edward A Dratz

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Neuroproteomics in Epilepsy: What Do We Know so Far?Frontiers in molecular neuroscience · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Gal Keren-AviramDepartment of Chemistry & Biochemistry, Montana State University, Bozeman, Montana, United States of America.
Fabien DachetThe Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan, United States of America.ORCID 0000-0002-5146-3449
Shruti BaglaThe Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan, United States of America.
Karina BalanThe Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan, United States of America.
Jeffrey A LoebThe Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan, United States of America.
Edward A DratzDepartment of Chemistry & Biochemistry, Montana State University, Bozeman, Montana, United States of America.
Wayne State University · USMontana State University · US

Funding

SYSTEMS BIOLOGY OF HOST-PATHOGEN INTERACTIONSP20RR024237 · NCRR · MONTANA STATE UNIVERSITY - BOZEMAN · PI SINGEL, DAVID J · 2008 to 2011
$8.1M
Activity-Dependent Gene Expression in Human EpilepsyR01NS045207 · NINDS · WAYNE STATE UNIVERSITY · PI LOEB, JEFFREY A · 2003 to 2010
$2.1M
Electrical, Molecular and Clinical Correlates of Human Interictal SpikingR01NS058802 · NINDS · WAYNE STATE UNIVERSITY · PI LOEB, JEFFREY A · 2008 to 2012
$1.6M
Multiplex Fluorescent Dyes for Ultrasensitive ProteomicsR42RR021790 · NCRR · ZDYE, LLC · PI DRATZ, EDWARD A · 2008 to 2010
$1.1M
MULTIPLEX ANALYSIS OF FUNCTIONAL PROTEOMICS: R-21R21RR016240 · NCRR · MONTANA STATE UNIVERSITY (BOZEMAN) · PI DRATZ, EDWARD A · 2002 to 2004
$412k
MAPK Signaling in Neocortical EpilepsyR56NS083527 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LOEB, JEFFREY A · 2015 to 2015
$400k
NCRR NIH HHS P20 RR024237NCRR NIH HHS R21 RR016240NCRR NIH HHS R42 RR021790NIH HHS P20GM104935NIH HHS P20RR024237NIH HHS R01NS045207NIH HHS R01NS058802NIH HHS R21RR16240NIH HHS R42RR021790NIH HHS R56 NS083527NINDS NIH HHS R01 NS045207NINDS NIH HHS R01 NS058802NINDS NIH HHS R56 NS083527
6 · The paper itself

Abstract

Epilepsy is a common neurological disorder, which is not well understood at the molecular level. Exactly why some brain regions produce epileptic discharges and others do not is not known. Patients who fail to respond to antiseizure medication (refractory epilepsy) can benefit from surgical removal of brain regions to reduce seizure frequency. The tissue removed in these surgeries offers an invaluable resource to uncover the molecular and cellular basis of human epilepsy. Here, we report a proteomic study to determine whether there are common proteomic patterns in human brain regions that produce epileptic discharges. We analyzed human brain samples, as part of the Systems Biology of Epilepsy Project (SBEP). These brain pieces are in vivo electrophysiologically characterized human brain samples withdrawn from the neocortex of six patients with refractory epilepsy. This study is unique in that for each of these six patients the comparison of protein expression was made within the same patient: a more epileptic region was compared to a less epileptic brain region. The amount of epileptic activity was defined for each patient as the frequency of their interictal spikes (electric activity between seizures that is a parameter strongly linked to epilepsy). Proteins were resolved from three subcellular fractions, using a 2D differential gel electrophoresis (2D-DIGE), revealing 31 identified protein spots that changed significantly. Interestingly, glial fibrillary acidic protein (GFAP) was found to be consistently down regulated in high spiking brain tissue and showed a strong negative correlation with spike frequency. We also developed a two-step analysis method to select for protein species that changed frequently among the patients and identified these proteins. A total of 397 protein spots of interest (SOI) were clustered by protein expression patterns across all samples. These clusters were used as markers and this analysis predicted proteomic changes due to both histological differences and molecular pathways, revealed by examination of gene ontology clusters. Our experimental design and proteomic data analysis predicts novel glial changes, increased angiogenesis, and changes in cytoskeleton and neuronal projections between high and low interictal spiking regions. Quantitative histological staining of these same tissues for both the vascular and glial changes confirmed these findings, which provide new insights into the structural and functional basis of neocortical epilepsy.

Indexed as

ProteomicsAdolescentAdultBlood VesselsChild, PreschoolEpilepsyFemaleGene Expression ProfilingHumansInfantMaleNeocortexNeuroglia

Identifiers

PMID29634780
PMCPMC5892923
OpenAlexW2796717065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.